Vitamin D in Breastfed Infants: Systematic Review of Alternatives to Daily Supplementation
Authors:
Open Access
- 1 January 2020
- journal article
- review article
- Published by Elsevier in Advances in Nutrition
- Vol. 11 (1) , 144-159
Abstract
Daily oral vitamin D supplementation (400 IU) is recommended for breastfeeding infants (≤1 y). Recent studies have examined alternative approaches to preventing vitamin D deficiency in this population. This systematic review and meta-analysis aimed to estimate the effects of maternal postpartum (M-PP) or infant intermittent (I-INT) vitamin D supplementation on infant 25-hydroxyvitamin D [25(OH)D] concentrations in comparison to routine direct infant daily (I-D) oral supplementation (400 IU). MEDLINE, MEDLINE In-Process, Embase, the Cochrane Database of Systematic Reviews, and the Cochrane Central Register of Controlled Trials were searched up to December 2018. Inclusion criteria consisted of published, peer-reviewed, vitamin D intervention trials involving lactating women and/or exclusively or partially breastfed term infants. Two reviewers independently extracted study characteristics (e.g., sample size, intervention dose, and duration and mode of administration) and related biochemical and clinical outcomes. Of 28 included trials, 5 randomized controlled trials were incorporated in meta-analyses examining infant 25(OH)D. Overall, M-PP supplementation resulted in modestly lower infant 25(OH)D compared with I-D supplementation (weighted mean difference = −8.1 nmol/L; 95% CI: −15.4, −0.9; I2 = 45%; P = 0.14; 3 trials), but the 2 most recent trials found M-PP to achieve similar infant 25(OH)D as I-D. Comparison of I-INT with I-D was confined to 2 trials with contradictory findings, and it was considered inappropriate for pooled analysis. Meta-analysis was therefore limited by a small number of eligible trials with variable quality of analytically derived 25(OH)D data and inconsistent reporting of safety outcomes, including effects on calcium homeostasis. Considering all 28 included trials, this systematic review highlights M-PP and I-INT regimens as plausible substitutes for routine daily infant vitamin D supplementation, but evidence remains too weak to support a policy update. Dose-ranging, adequately powered trials are required to establish the efficacy, safety, and feasibility of alternative strategies to prevent vitamin D deficiency in breastfeeding infants. This review was registered with PROSPERO as CRD42017069905.Keywords
Funding Information
- SickKids Centre for Global Child Health Growth and Development Fellowship
- Canadian Institute of Health Research
- Canada Graduate Scholarships Master's Competition
This publication has 64 references indexed in Scilit:
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Effect of weekly vitamin D supplements on mortality, morbidity, and growth of low birthweight term infants in India up to age 6 months: randomised controlled trialBMJ, 2011
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Interventions for the prevention of nutritional rickets in term born childrenCochrane Database of Systematic Reviews, 2007
- Who, what, where and when—influences on cutaneous vitamin D synthesisProgress in Biophysics and Molecular Biology, 2006
- High-Dose Vitamin D 3 Supplementation in a Cohort of Breastfeeding Mothers and Their Infants: A 6-Month Follow-Up Pilot StudyBreastfeeding Medicine, 2006
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Ultraviolet Light: A Hazard to ChildrenPediatrics, 1999
- Maternal compared with infant vitamin D supplementation.Archives of Disease in Childhood, 1986
- Maternal-infant vitamin D relationships during breast-feedingThe Journal of Pediatrics, 1982